Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 4/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Peace Sandy on 2024-4-9
Source: Table 2 and Text
Description: 16S rRNA analysis showing the differences in the relative abundance of microbiota composition between Parkinson's Disease Patients with normal Calprotectin levels and Calprotectin positive Parkinson's Disease Patients'
Abundance in Group 1: increased abundance in Parkinson's Disease Patients with normal Calprotectin levels
NCBI | Quality Control | Links |
---|---|---|
Faecalibacterium |
Revision editor(s): FaithAlexander